CLINICAL_TRIALS
trial_result
· 2017-07-19
Clinical Trial Update: Therapy of Chronic Cold Agglutinin Disease With Eculizumab [Phase 2]
Summary
This document reports a completed Phase 2 clinical trial evaluating eculizumab for Cold agglutinin disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Essen | Conditions: Cold Agglutinin Disease | Phase 2 | Status: COMPLETED